2021-01-07,"SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CHNG, BPFH, RP, MDCA, NK; Shareholders Are Encouraged to Contact the Firm"
2021-01-06,"NantKwest Executive Chairman Dr. Patrick Soon-Shiong to Present at 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021"
2021-01-05,"WeissLaw LLP Reminds RNET, NK, HMSY, and QEP Shareholders About Its Ongoing Investigations"
2021-01-05,"NANTKWEST ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of NK and Encourages Investors to Contact the Firm"
2021-01-02,"MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages NK, PRGX, CBLI, and IPHI Shareholders to Contact the Firm"
2020-12-30,STOCKHOLDER ALERT: Monteverde & Associates Launches Legal Investigation for the Following Transaction
2020-12-30,"SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers  WTRE, ARA, RESI, NK"
2020-12-30,New Strong Sell Stocks for December 30th
2020-12-30,Here's a Cancer-Killing Stock to Buy for 2021
2020-12-29,"WeissLaw LLP Reminds RNET, NK, HMSY, and QEP Shareholders About Its Ongoing Investigations"
2020-12-29,"NANTKWEST INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NantKwest, Inc. - NK"
2020-12-28,"SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - PRGX, STND, NK, EIDX, ARA"
2020-12-28,"SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of NantKwest, Inc. (NK) and Encourages Shareholders to Contact the Firm"
2020-12-28,"NANTKWEST (NK) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of NantKwest, Inc."
2020-12-24,"NantKwest Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of NantKwest, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm  NK"
2020-12-23,"SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of NantKwest, Inc. - NK"
2020-12-23,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of NantKwest, Inc. Merger"
2020-12-22,"SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of NantKwest, Inc.  NK"
2020-12-22,5 Medical Outperformers That Might Lose Steam in 2021
2020-12-21,"SHAREHOLDER ALERT: WeissLaw LLP Investigates NantKwest, Inc."
2020-12-21,"SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of NantKwest, Inc. (Nasdaq - NK)"
2020-12-21,Why NantKwest Is Jumping Today
2020-12-21,"Biopharma M&A Continues: Agios Sells Oncology Portfolio, NantKwest's Reverse Merger With ImmunityBio, Eyegate Picks Up Panoptes"
2020-12-21,ImmunityBio Announces Primary Endpoint Met of Phase 2/3 Trial for BCG Unresponsive Non-Muscle Invasive Bladder Cancer CIS with 72% Complete Response Rate
2020-12-21,"ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy Company"
2020-12-10,Is NK A Good Stock To Buy Now?
2020-12-10,ImmunityBios hAd5 T-Cell COVID-19 Vaccine Candidate Shows Complete Protection of Airways in Non-Human Primates
2020-12-09,"How Much Are NantKwest, Inc. (NASDAQ:NK) Insiders Spending On Buying Shares?"
2020-12-07,"Good vaccine news and a flurry of stock sales by executives. There's a pattern, study finds"
2020-11-23,ImmunityBio Announces Publication of Preclinical Data Demonstrating IL-15 Superagonist N-803 Improves Natural Killer-Mediated Tumor Cell Killing
2020-11-18,NantKwest to Participate in the 32nd Annual Piper Sandler Healthcare Conference
2020-11-10,"ImmunityBio, NantKwest Announce Positive Interim Phase 1 Safety Data of hAd5 COVID-19 Vaccine Dose Study"
2020-11-09,Covid-Tied Biotechs Unwind Gains After Pfizer Vaccine Data
2020-11-09,ImmunityBios hAd5 COVID-19 Vaccine Candidate Stimulates Memory T-Cell Recall in Patients Infected with SARS-CoV-2
2020-10-26,NantKwest Names Richard Adcock Chief Executive Officer
2020-10-21,"ImmunityBio, NantKwest Announce First Patient Dosed in Phase 1 Clinical Trial of Second-Generation COVID-19 Vaccine Candidate Delivering Both Spike and Nucleocapsid of SARS-CoV-2"
2020-10-15,FDA Authorizes Phase 1 Trial of ImmunityBios Novel COVID-19 Vaccine Candidate hAd5; Dual Construct is Designed to Drive Both T Cell and Antibody Immunity
2020-10-06,"NantKwest, ImmunityBio Add Third-Line Cohort to Phase 2 Pancreatic Cancer Trial; Opens Study to Patients Who Have Failed All Approved Standards of Care"
2020-10-05,Companies Like NantKwest (NASDAQ:NK) Are In A Position To Invest In Growth
2020-09-21,NantKwest to Present at the 7th Annual Jefferies Cell Therapy Summit
2020-09-10,Brink Biologics Announces License Agreement with Global Healthcare Company Fresenius Kabi SwissBioSim GmbH
2020-08-24,"NantKwest and ImmunityBio Sign Collaboration Agreement for Joint Development, Manufacturing, Marketing, and Commercialization of COVID-19 Vaccine and Related Therapeutics"
2020-08-19,"Do Insiders Own Lots Of Shares In NantKwest, Inc. (NASDAQ:NK)?"
2020-08-10,Cord Blood Registry (CBRÂ®) By Generate Life Sciences Partners With NantKwest To Develop COVID-19 Treatment
2020-07-28,Analysts Estimate NantKwest (NK) to Report a Decline in Earnings: What to Look Out for
2020-07-06,Weekly CEO Buys Highlight
2020-07-02,"The Executive Chairman & CEO of NantKwest, Inc. (NASDAQ:NK), Patrick Soon-Shiong, Just Bought 6.1% More Shares"
2020-06-29,NantKwest Announces Closing of $90.7 Million Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-06-29,Race for a COVID-19 vaccine has drug makers scaling up manufacturing  before one is developed
2020-06-25,NantKwest Announces Pricing of Public Offering of Common Stock
2020-06-24,NantKwest Announces Proposed Public Offering of Common Stock
2020-06-10,NantKwest Announces Studies in Collaboration with the National Cancer Institute Demonstrating Enhanced Killing Activity of First-in-Class PD-L1 t-haNK Natural Killer Cell Across Every Cancer Cell Line Tested
2020-05-31,Hedge Funds Cashing Out Of Nantkwest Inc (NK)
2020-05-27,"NantKwest Vaccine Now Part Of 'Operation Warp Speed,' Lays Out Plan For COVID-19 Candidates"
2020-05-27,"ImmunityBio & NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for Operation Warp Speed to Develop Novel Adenovirus COVID-19 Vaccine"
2020-05-26,NantKwest and ImmunityBio to Present at the Jefferies Virtual Healthcare Conference
2020-05-19,Be The Match BioTherapies and NantKwest Announce Collaboration to Accelerate Development of Cell Therapy to Prevent COVID-19 Deaths
2020-05-18,NantKwest Announces FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19 Patients
2020-05-15,"The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO"
2020-05-14,NantKwest and ImmunityBio to Initiate a Phase 2 Study of Immunotherapy for Metastatic Pancreatic Cancer
2020-04-29,NantKwest and ImmunityBio to Present at the Bank of America Merrill Lynch Global Healthcare Conference
2020-04-14,NantKwest aims to start clinical trials for COVID-19 vaccine by June
2020-04-14,"NantKwest In 'Active Discussions' With FDA On COVID-19 Vaccine, Therapeutic Development"
2020-04-14,NantKwest and ImmunityBio Announce Therapeutics and Vaccines for Combatting COVID-19; Clinical Trials Anticipated to Begin This Quarter
2020-03-19,NantKwest Doses First Patient in Phase 2 Single-Arm Trial of Metastatic Merkel Cell Carcinoma Therapy With Off-the-Shelf CD16 Natural Killer Cells
2020-01-17,Options Traders Expect Huge Moves in NantKwest (NK) Stock
2020-01-16,Progress Report on Cancer Breakthroughs 2020 Project Presented by Dr. Soon-Shiong at J.P. Morgan Healthcare Conference
2020-01-14,NantKwest and ImmunityBio Announce Complete Response in Metastatic Pancreatic Cancer in the First Patient to Receive PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) Combined with N-803 IL-15 Fusion Protein
2020-01-13,NantKwest Gains 91% After CEO Shares Promising Cancer Result
2020-01-06,Investors Who Bought NantKwest (NASDAQ:NK) Shares A Year Ago Are Now Up 199%
2019-12-20,Here is What Hedge Funds Think About Nantkwest Inc (NK)
2019-12-16,"NantKwest and ImmunityBio Present Results of Landmark Trial of First-in-Human Natural Killer Cell Combination Immunotherapy With Durable, Complete Response Data and 78% Disease Control in Refractory Triple Negative Breast Cancer at SABCS"
2019-12-03,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial"
2019-12-02,NantKwest Announces Phase 1 Results for First-in-Human PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) in Patients with Locally Advanced or Metastatic Solid Cancers
2019-11-27,"NantKwest Hosting Key Opinion Leader Meeting on Novel Immunotherapeutic Approaches to Address the Unmet Medical Needs of Patients with Merkel Cell Carcinoma, Triple-Negative Breast Cancer and Solid Tumors"
2019-11-07,NantKwest Announces Presentation of Positive Phase 2 Clinical Data of Natural Killer Cell Therapy in Metastatic Merkel Cell Carcinoma at SITC 2019
2019-11-07,"What Kind Of Shareholder Owns Most NantKwest, Inc. (NASDAQ:NK) Stock?"
2019-10-02,"Does NantKwest, Inc.'s (NASDAQ:NK) CEO Pay Reflect Performance?"
2019-08-27,"Who Has Been Selling NantKwest, Inc. (NASDAQ:NK) Shares?"
2019-07-11,Did Changing Sentiment Drive NantKwest's (NASDAQ:NK) Share Price Down A Painful 82%?
2019-06-24,"NantKwest Launches First-in-class, First-in-human Phase I Clinical Trial With a Targeted PD-L1 t-haNK Cell Therapy in Patients With Solid Tumors"
2019-06-06,Cheryl Cohen Appointed to NantKwests Board of Directors
2019-06-04,NantKwest Announces Durable Complete Responses in Multiple Advanced-Stage Solid Tumor Cancers Following Off-the-Shelf NK Cell Therapy in First 35 Patients
2019-06-04,"NantKwest Announces Updated Clinical Results for Nanatinostat (VRx-3996), a Novel HDAC Inhibitor Being Developed in Partnership with Viracta Therapeutics"
2019-06-03,NantKwest Launches First-in-Human Targeted NK Phase I Clinical Trial of CD19 T-haNK Cell Therapy in Lymphoma Patients
2019-06-03,NantKwest to Present and Provide Update at Upcoming Jefferies 2019 Annual Healthcare Conference
2019-05-31,"NantKwest, NantCell and NantOmics to Provide Updated Preclinical and Clinical Data in Four Abstracts at Part of the American Society of Clinical Oncology Annual Meeting"
2019-05-23,"What Kind Of Investor Owns Most Of NantKwest, Inc. (NASDAQ:NK)?"
2019-05-01,Brink Biologics Announces Research License AgreementÂ withÂ Worcester Polytechnic InstituteÂ for Use of NantKwests NK-92Â®Â Cells
2019-04-01,NantKwest Announces New haNK Natural Killer Cell Patent Issuance Further Expanding Intellectual Property Estate
2019-04-01,Will NantKwest Continue to Surge Higher?
2019-03-25,NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants and Options in Support of NKs Natural Killer Cell Strategic Vision Beyond Check Point Immunotherapy
2019-03-18,NantKwest Chairman & CEO Dr. Patrick Soon-Shiong to Present Vision for Next Generation Natural Killer Cell Therapies During Keynote Address at Innate Killer Summit
2019-03-04,NantKwest Signs Worldwide License Agreement with ProMab Biotechnologies to ExclusivelyÂ Develop Select Next Generation Targeted Natural Killer Cell Therapeutics
2019-02-25,"Our Take On NantKwest, Inc.s (NASDAQ:NK) CEO Salary"
2019-01-10,Is the Options Market Predicting a Spike in NantKwest (NK) Stock?
2019-01-09,NantKwest Announces Launch of Merkel Cell Carcinoma Phase II Trial Deploying Novel Triple Combination of off-the-Shelf Natural Killer haNK Cell Therapy with Superagonist IL-15 Cytokine Therapy and PD-L1 Checkpoint Inhibitor Therapy
2019-01-07,Soon-Shiongs NantCell gets $30 million from Celgene
2019-01-05,NantKwest to Host 4th Annual Investor/Analyst Day Highlighting Industry Leading R&D and Clinical Programs
2018-12-25,"Have Insiders Been Selling NantKwest, Inc. (NASDAQ:NK) Shares?"
